Cargando…

Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies

In the ever-changing landscape of device therapy for pulmonary embolism, it is important to understand the rationale behind the ongoing explosion in the development of new device therapies. There needs to be an in-depth understanding of risk stratification in pulmonary embolism and indications for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Caleb, Attanasio, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615215/
https://www.ncbi.nlm.nih.gov/pubmed/34825874
http://dx.doi.org/10.2174/1573403X17666211126092110
_version_ 1784820372295647232
author Chiang, Caleb
Attanasio, Steve
author_facet Chiang, Caleb
Attanasio, Steve
author_sort Chiang, Caleb
collection PubMed
description In the ever-changing landscape of device therapy for pulmonary embolism, it is important to understand the rationale behind the ongoing explosion in the development of new device therapies. There needs to be an in-depth understanding of risk stratification in pulmonary embolism and indications for therapy. Selecting the ideal device for a particular pulmonary embolism subset remains elusive and poorly defined. Knowledge of the risks, benefits, capabilities, and potential limitations of each device is crucial.
format Online
Article
Text
id pubmed-9615215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-96152152023-05-26 Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies Chiang, Caleb Attanasio, Steve Curr Cardiol Rev Article In the ever-changing landscape of device therapy for pulmonary embolism, it is important to understand the rationale behind the ongoing explosion in the development of new device therapies. There needs to be an in-depth understanding of risk stratification in pulmonary embolism and indications for therapy. Selecting the ideal device for a particular pulmonary embolism subset remains elusive and poorly defined. Knowledge of the risks, benefits, capabilities, and potential limitations of each device is crucial. Bentham Science Publishers 2022-05-26 2022-05-26 /pmc/articles/PMC9615215/ /pubmed/34825874 http://dx.doi.org/10.2174/1573403X17666211126092110 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Chiang, Caleb
Attanasio, Steve
Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
title Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
title_full Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
title_fullStr Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
title_full_unstemmed Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
title_short Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
title_sort concise review of the rationale for pulmonary embolism treatment and endovascular device therapies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615215/
https://www.ncbi.nlm.nih.gov/pubmed/34825874
http://dx.doi.org/10.2174/1573403X17666211126092110
work_keys_str_mv AT chiangcaleb concisereviewoftherationaleforpulmonaryembolismtreatmentandendovasculardevicetherapies
AT attanasiosteve concisereviewoftherationaleforpulmonaryembolismtreatmentandendovasculardevicetherapies